Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_assertion type Assertion NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_head.
- NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_assertion description "[Thus, this study provides new evidence that NAC-1 upregulation and homodimerization contribute to tumor recurrence by equipping ovarian cancer cells with the paclitaxel-resistant phenotype through negative regulation of the Gadd45 pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_provenance.
- NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_assertion evidence source_evidence_literature NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_provenance.
- NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_assertion SIO_000772 19305429 NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_provenance.
- NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_assertion wasDerivedFrom befree-20150227 NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_provenance.
- NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_assertion wasGeneratedBy ECO_0000203 NP351100.RA5a05g_O_gAgmr-1QikxvvGpxdXXTIr_hg3osv1khua4130_provenance.